PROCESS FOR PREPARATION OF TENELIGLIPTIN Russian patent published in 2018 - IPC C07D417/14 A61K31/401 A61K31/427 A61K31/496 

Abstract RU 2654069 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a process for the preparation of teneligliptin, a compound of formula I, or a salt thereof, or a hydrate thereof. Process comprises a) reacting a compound of formula 11 with bis-(2-chloroethyl)amine, or an N-protected derivative thereof, or a salt thereof, to obtain a compound of formula Int-B, or an N-protected derivative thereof, or a salt thereof or a) reacting 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde, a compound of formula 30, with piperazine-1-carboxylic acid tert-butyl ester to obtain tert-butyl-4-(4-formyl-3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate, a compound of formula 31, which is then deprotected to obtain a compound of formula Int-B; b) reacting a compound of formula Int-B, or an N-protected derivative thereof, or a salt thereof with a compound of formula 13 to obtain a compound of formula 14 wherein R is an amino protecting group selected from the group consisting of aralkyl, acyl, lower alkoxycarbonyl, aralkyloxycarbonyl, lower alkanesulfonyl, arylsulfonyl, tri- (lower alkyl) silyl, triphosgene; and c) deprotecting the compound of formula 14 to produce teneligliptin, a compound of formula I, or a salt thereof or a hydrate thereof. Invention also relates to a process for the preparation of teneligliptin 2,5 hydrobromide hydrate, which comprises the crystallisation of teneligliptin 2,5 hydrobromide or a hydrate thereof from a solvent selected from the group consisting of methanol, n-butanol, t-butanol, dimethylacetamide, dimethylformamide, tetrahydrofuran, and mixtures thereof.

, , , , , .

EFFECT: processes according to the invention enables to obtain teneligliptin or its salts with high yields and purity.

8 cl, 5 dwg, 18 ex

Similar patents RU2654069C2

Title Year Author Number
COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS 2014
  • Bair Kenneth W.
  • Herbertz Torsten
  • Kauffman Goss Stryker
  • Kayser-Bricker Katherine J.
  • Luke George P.
  • Martin Matthew W.
  • Millan David S.
  • Schiller Shawn E. R.
  • Talbot Adam C.
  • Tebbe Mark J.
RU2720237C2
ANTIBACTERIAL AGENT 2000
  • Prehtt Liza Mehri
  • Kiavej Kennet Noehl
  • Pehjn Gils Denis
  • Mun'E Loran Frank
RU2269525C2
PYRAZOLE-BASED MAGL INHIBITORS 2018
  • Grajs, Sheril A.
  • Viner, Dzhon Dzh.M.
  • Veber, Oliviya D.
  • Dunkan Katarina K.
RU2789157C2
DOSAGE FORMS CONTAINING TENELIGLIPTIN OXALATE SALTS AND SOLVATES THEREOF 2018
  • Kadam Suresh Makhadev
  • Kansagra Bipin Parsottam
  • Kale Shrikrishna Kantilal
  • Bkhirud Shekkhar Bkhaskar
  • Dvivedi Radzhesh Kumar
  • Dkhuppad Ulkhas Rameshchandra
  • Deshmukkh Nitin Shivadzhirao
  • Sadafal Krishna Prakashrao
RU2742418C1
NOVEL INDOLYSIN COMPOUNDS, METHOD FOR PRODUCING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF 2014
  • Le-Tiran Arno
  • Le-Digore Terri
  • Stark Zherom-Benua
  • Anlen Zhan-Mishel
  • De-Nantej Gijom
  • Zhanest Olive
  • Dejvidson Dzhejms Eduard Pol
  • Marri Dzhejms Bruk
  • Chen Itszen
RU2693629C2
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES 2011
  • Din Khun
  • Ehlmor Stiven
  • Kheksamer Laura
  • Kanzer Aaron R.
  • Park Cheol-Min
  • Sauehrs Ehndrju Dzh.
  • Sallivan Dzherard
  • Uehndt Majkl
RU2568611C2
AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS 2004
  • Jao Vehn'Tsin
  • Chzho Tszin'Tsun
  • Ksu Mehjchzhun
  • Chzhan Fehnlehj
  • Metkaf Brajan
RU2379303C2
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF 2012
  • Bungard Kristofer Dzhejms
  • Konverso Antonella
  • De Leon Pablo
  • Khanni Barbara
  • Kharting Timoti Dzhon
  • Manikovski Dzhess Dzhozef
  • Menli Piter Dzh.
  • Mejssner Robert
  • Myn Chzhaoyan
  • Perkins Dzhejms Dzh.
  • Radd Majkl T.
  • Shu Yukhen
RU2610262C2
CRYSTALLINE DERIVATIVES OF 1-METHYLCARBAPENEM 2000
  • Kavamoto Isao
  • Simodzi Jasuo
  • Fukukhara Khirosi
RU2214411C2
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR 2017
  • Zhu Li
  • Hu Yuandong
  • Wu Wei
  • Dai Liguang
  • Duan Xiaowei
  • Yang Yanqing
  • Sun Yinghui
  • Han Yongxin
  • Peng Yong
  • Kong Fansheng
  • Luo Hong
  • Yang Ling
  • Xu Hongjiang
  • Guo Meng
  • Wang Shanchun
  • Zhong Zhaobai
RU2764523C2

RU 2 654 069 C2

Authors

Kadam Suresh Makhadev

Kansagra Bipin Parsottam

Kale Ramchandran Vishnu

Patil Dzhajant Prakashrao

Emireddi Venkataramana Reddi

Bkhadane Shajlendra Nilkantkh

Chaudkhar Uddkhav Popat

Patil Ulkhas Digambar

Bkhirud Shekkhar Bkhaskar

Dates

2018-05-16Published

2013-08-28Filed